HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients

Objectives Cognitive impairment remains frequent in HIV, despite combination antiretroviral therapy (cART). Leading theories implicate peripheral monocyte HIV DNA reservoirs as a mechanism for spread of the virus to the brain. These reservoirs remain present despite cART. The objective of this study was to determine if the level of HIV DNA in CD14+ enriched monocytes predicted cognitive impairment and brain injury. Methods We enrolled 61 cART-naïve HIV-infected Thais in a prospective study and measured HIV DNA in CD14+ enriched monocyte samples in a blinded fashion. We determined HAND diagnoses by consensus panel and all participants underwent magnetic resonance spectroscopy (MRS) to measure markers of brain injury. Immune activation was measured via cytokines in cerebrospinal fluid (CSF). Results The mean (SD) age was 35 (6.9) years, CD4 T-lymphocyte count was 236 (139) and log10 plasma HIV RNA was 4.8 (0.73). Twenty-eight of 61 met HAND criteria. The log10 CD14+ HIV DNA was associated with HAND in unadjusted and adjusted models (p = 0.001). There was a 14.5 increased odds ratio for HAND per 1 log-value of HIV DNA (10-fold increase in copy number). Plasma CD14+ HIV DNA was associated with plasma and CSF neopterin (p = 0.023) and with MRS markers of neuronal injury (lower N-acetyl aspartate) and glial dysfunction (higher myoinositol) in multiple brain regions. Interpretation Reservoir burden of HIV DNA in monocyte-enriched (CD14+) peripheral blood cells increases risk for HAND in treatment-naïve HIV+ subjects and is directly associated with CSF immune activation and both brain injury and glial dysfunction by MRS.

[1]  V. Valcour,et al.  HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications , 2010, Journal of leukocyte biology.

[2]  P. Simmonds,et al.  HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. , 1998, Brain : a journal of neurology.

[3]  W. Kantakamalakul,et al.  Surveillance of subtype and genetic variation of the circulating strains of HIV-1 in Thailand. , 2007, The Southeast Asian journal of tropical medicine and public health.

[4]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[5]  M. Maj,et al.  WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. , 1994, Archives of general psychiatry.

[6]  C. Schwartz,et al.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage , 2010, Retrovirology.

[7]  O. Lambotte,et al.  Detection of Infectious HIV in Circulating Monocytes From Patients on Prolonged Highly Active Antiretroviral Therapy , 2000, Journal of acquired immune deficiency syndromes.

[8]  C. Rouzioux,et al.  HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  P. Simmonds,et al.  Influence of HAART on HIV-related CNS disease and neuroinflammation. , 2005, Journal of neuropathology and experimental neurology.

[10]  C. Rouzioux,et al.  Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. , 2005, The Journal of infectious diseases.

[11]  V. Wojna,et al.  Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders , 2013, AIDS.

[12]  J. Ananworanich,et al.  Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy , 2011, Journal of NeuroVirology.

[13]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[14]  R. Paul,et al.  Antiretroviral Monocyte Efficacy Score Linked to Cognitive Impairment in Hiv , 2012, Antiviral therapy.

[15]  L. Wald,et al.  Theory and application of array coils in MR spectroscopy , 1997, NMR in biomedicine.

[16]  V. Valcour,et al.  Circulating proviral HIV DNA and HIV-associated dementia , 2005, AIDS.

[17]  James R. Anderson,et al.  Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. , 2001, The Journal of infectious diseases.

[18]  R. Paul,et al.  Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection , 2007, Neurology.

[19]  R. Paul,et al.  HIV DNA and cognition in a Thai longitudinal HAART initiation cohort , 2009, Neurology.

[20]  C. Coleman,et al.  Retrovirology BioMed Central Review HIV interactions with monocytes and dendritic cells: viral latency and reservoirs , 2009 .

[21]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Ning Li,et al.  Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China , 2013, Journal of NeuroVirology.

[23]  D P Auer,et al.  On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.

[24]  Yujie Liu,et al.  Cellular reservoirs of HIV-1 and their role in viral persistence. , 2008, Current HIV research.

[25]  Jintanat Ananworanich,et al.  Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders , 2013, Journal of clinical and experimental neuropsychology.

[26]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[27]  Praphan Phanuphak,et al.  Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010 , 2010 .

[28]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.